论文部分内容阅读
目的对应用思密达与金双歧联合对患有腹泻的患儿进行治疗的临床效果进行研究分析。方法抽取90例患有腹泻的临床确诊患儿病例,将其分为A、B两组,平均每组45例。A组患儿采用思密达进行治疗;B组患儿采用思密达与金双歧联合进行治疗。结果 B组患儿治疗后的腹泻症状改善效果明显优于A组;治疗后腹泻、腹痛、发热等症状表现的好转或消失时间明显早于A组;治疗过程中出现药物不良反应的人数明显少于A组。结论应用思密达与金双歧联合对患有腹泻的患儿进行治疗的临床效果非常明显。
Objective To study the clinical effect of Smecta and Jinshuangqi on the treatment of children with diarrhea. Methods Totally 90 cases of clinically diagnosed children with diarrhea were divided into two groups A and B, with an average of 45 cases in each group. A group of children with Smectite for treatment; B group of children with Smectite and Golden Bifu joint treatment. Results The improvement effect of diarrhea symptom after treatment in group B was better than that in group A; the improvement or disappearance of symptoms such as diarrhea, abdominal pain and fever were obviously earlier than those in group A; the number of adverse drug reactions in treatment was significantly less In Group A Conclusion The clinical effect of Smecta combined with bifidobacterium on the treatment of children with diarrhea is very obvious.